Image Credit: India Pharma Outlook Announcement Sandoz, a known leader in producing affordable medicines, has entered the US with its generic iron sucrose injection with the approval of the US Food and Drug Administration (FDA). The product is marketized and also ready for delivery and order thr...
Image Credit: Oxford University Innovation Announcement Pepgen Inc., a leading clinical-level biotechnology company advancing the next generation future of oligonucleotide therapies with a motive of transitioning the treatment of neurological disease and extreme neuromuscular, declared that they...
Image Credit: Ricoh USA Announcement Agility, a known provider and manufacturer of medical device solutions to the US healthcare industry, has extended its advanced oncology offering to hospitals and physicians, with the highest value and availability to focal therapy services for treating and d...
Image Credit: Cinical Lab Products Announcement Myriad Genetics, a known face of precision medicine and molecular diagnostic testing, and Sophia Genetics, a leading AI technology company revolutionizing precision medicine, have entered a smart partnership to offer and develop pharmaceutical comp...
Image Credit: Ncardia Announcement Ncardia, a known face in stem cell-related solutions for drug safety assessment and discovery, launched ncyte NHP-C vCardiomyocytes, the first ever available ventricular cardiomyocytes at the commercial stage. It is derived from the induced pluripotent stem cel...
Announcement Eli Lilly and Company intends to build a new manufacturing facility worth $6.5 billion at the Generation Park in Houston, Texas. This intensification of the future synthetic medicine active pharmaceutical product (API) facility, one of the second of the four new US sites Lilly will dec...
Image credit: Newdigit Announcement Newdigit, a leading organization continuously focusing on integrating clean energy into the agricultural and healthcare sectors, claims that they are evolving healthcare in Nigeria with medical-grade oxygen and a reliable source of electricity in hospitals via...
Image Credit: AInvest Announcement Patient Square Capital, an affiliate of an investment firm, acquired healthcare firm Premier with a finalized deal value of approximately $2.6 billion. Patient Square Capital will pay $28.25 in cash for each share for premier and 9.7% premium to the stock&rsquo...
Announcement The US Food and Drug Administration (FDA) has granted Sanofi’s SAR446268 a fast-track designation. It is Sanofi’s one-time AAV gene therapy for non-congenital (adult and juvenile onset) DM1 myotonic dystrophy type 1 (DM1) treatment. The designation process focuses on adva...
Image Credits: Ontario Announcement The Ontario government has introduced the Health Innovation Pathway, a transformative initiative to leverage the response and integration of innovative health technologies and enhance patient care by raising funds for a total of four initial projects worth $12...
